126 related articles for article (PubMed ID: 12185899)
1. [Inactivation of p53 and amplification of cyclin D1 in squamous cell carcinomas of the head and neck].
Rodrigo Tapia JP; González Meana MV; García González LA; Coto E; García Pedrero J; Núñez Batalla F; Suárez Nieto C
Acta Otorrinolaringol Esp; 2002 Apr; 53(4):225-32. PubMed ID: 12185899
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer.
Nogueira CP; Dolan RW; Gooey J; Byahatti S; Vaughan CW; Fuleihan NS; Grillone G; Baker E; Domanowski G
Laryngoscope; 1998 Mar; 108(3):345-50. PubMed ID: 9504605
[TBL] [Abstract][Full Text] [Related]
3. Correlation between p53 mutation and cyclin D1 amplification in had and neck squamous cell carcinoma.
Mineta H; Borg A; Dictor M; Wahlberg P; Wennerberg J
Oral Oncol; 1997 Jan; 33(1):42-6. PubMed ID: 9192552
[TBL] [Abstract][Full Text] [Related]
4. [CCND1 oncogene amplification and cellular DNA content in squamous cell carcinomas of the head and neck].
Rodrigo Tapia JP; García González LA; Martínez Sánchez JA; González Meana MV; García Pedrero JM; Suárez Nieto C
Acta Otorrinolaringol Esp; 2001 Oct; 52(7):539-43. PubMed ID: 11692945
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between human papillomavirus and cyclin D1 gene amplification in squamous cell carcinomas of the head and neck].
Rodrigo Tapia JP; García González LA; Alvarez Alvarez I; Cabanillas Farpón R; Suárez Nieto C
Acta Otorrinolaringol Esp; 2005 Nov; 56(9):428-33. PubMed ID: 16353790
[TBL] [Abstract][Full Text] [Related]
6. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma.
Kyomoto R; Kumazawa H; Toda Y; Sakaida N; Okamura A; Iwanaga M; Shintaku M; Yamashita T; Hiai H; Fukumoto M
Int J Cancer; 1997 Dec; 74(6):576-81. PubMed ID: 9421351
[TBL] [Abstract][Full Text] [Related]
8. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.
Xu L; Davidson BJ; Murty VV; Li RG; Sacks PG; Garin-Chesa P; Schantz SP; Chaganti RS
Int J Cancer; 1994 Nov; 59(3):383-7. PubMed ID: 7927946
[TBL] [Abstract][Full Text] [Related]
9. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
[TBL] [Abstract][Full Text] [Related]
10. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
[TBL] [Abstract][Full Text] [Related]
11. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
12. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
13. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma.
el-Naggar AK; Steck K; Batsakis JG
Cytometry; 1995 Sep; 21(1):47-51. PubMed ID: 8529470
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma.
Davidson BJ; Lydiatt WM; Abate MP; Schantz SP; Chaganti RS
Head Neck; 1996; 18(6):512-21. PubMed ID: 8902564
[TBL] [Abstract][Full Text] [Related]
16. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
17. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
